Redmile Group, LLC - ATYR PHARMA INC ownership

ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120103. A total of 33 filers reported holding ATYR PHARMA INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Redmile Group, LLC ownership history of ATYR PHARMA INC
ValueSharesWeighting
Q2 2018$1,715,000
-65.7%
1,884,9920.0%0.06%
-69.9%
Q1 2018$4,995,000
-24.4%
1,884,992
-0.1%
0.19%
-32.8%
Q4 2017$6,604,000
-30.7%
1,886,7920.0%0.29%
-38.9%
Q3 2017$9,528,0001,886,7920.47%
Other shareholders
ATYR PHARMA INC shareholders Q3 2018
NameSharesValueWeighting ↓
Polaris Venture Management Co. V, L.L.C. 1,827,992$1,485,0000.74%
Artal Group S.A. 500,000$406,0000.01%
BOOTHBAY FUND MANAGEMENT, LLC 94,466$77,0000.01%
VIKING GLOBAL INVESTORS LP 1,384,300$1,125,0000.01%
Glen Harbor Capital Management LLC 153,238$125,0000.00%
Tyers Asset Management LLC 72,112$59,0000.00%
Elkfork Partners LLC 99,154$81,0000.00%
RIVERHEAD CAPITAL MANAGEMENT LLC 79,677$65,0000.00%
A.R.T. Advisors, LLC 43,316$35,0000.00%
Meadow Creek Investment Management LLC 126,196$103,0000.00%
View complete list of ATYR PHARMA INC shareholders